Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $6,562 MXN
Change Today +57.67 / 0.89%
Volume 100.0
As of 4:10 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John G. Cox

Executive Vice President of Pharmaceutical Operations & Technology, Biogen Idec Inc.
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 3 different industries.

See Board Relationships
51$3,671,597
As of Fiscal Year 2013

Background*

Mr. John G. Cox has been an Executive Vice President of Pharmaceutical Operations & Technology at Biogen Idec Inc. since June 2010. Mr. Cox oversees Biogen Idec's global manufacturing, technical development, supply chain, engineering and facilities operations across the globe. He joined Biogen Idec in 2003 and served as its Senior Vice President of Global Manufacturing and Operations. He served senior operational roles at Covance Biotech and American Home Products Corporation, ...

Read Full Background

Corporate Headquarters*

225 Binney Street
Cambridge, Massachusetts 02142

United States

Phone: 617-679-2000
Fax: --

Board Members Memberships*

2013-Present
Director

Education*

MBA
University of Michigan
MS
California State University
BS
Arizona State University-Tempe

Other Affiliations*

Annual Compensation*

Salary$625,648
Total Annual Compensation$625,648

Stock Options*

Restricted Stock Awards$2,247,885
All Other Compensation$201,061
Exercisable Options15,546
Exercisable Options Value$3,460,740
Total Value of Options$3,460,740
Total Number of Options15,546

Total Compensation*

Total Annual Cash Compensation$1,417,982
Total Short Term Compensation$625,648
Other Long Term Compensation$2,448,946
Total Calculated Compensation$3,671,597
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIIB*:MM $6,562.00 MXN +57.67

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
Robert J. Hugin MBAChairman, Chief Executive Officer and Chairman of Executive Committee
Celgene Corporation
$1.3M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
kr15.2M
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
¥170.0M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOGEN IDEC INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.